SCHEMBL9305089

SCHEMBL9305089

C(=N/c1ccccc1)\c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
KMT2A Q03164 6/20 0.54
GRIN2D O15399 2/20 0.51
GRIN3B O60391 2/20 0.51
GRIN1 Q05586 2/20 0.51
GRIN2A Q12879 2/20 0.51
GRIN2B Q13224 2/20 0.51
GRIN2C Q14957 2/20 0.51
GRIN3A Q8TCU5 2/20 0.51
HSD17B10 Q99714 2/20 0.50
TSHR P16473 1/20 0.50
POLB P06746 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
SIRT2 Q8IXJ6 1/20 0.47
ALDH1A1 P00352 3/20 0.46
PKM P14618 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 2/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9305094 1.00 MAPT (0.54) MAPTKMT2AGRIN2DGRIN3BGRIN1
SCHEMBL11339219 0.94 SIRT2 (0.53) MAPTKMT2AGRIN2DGRIN3BGRIN1
SCHEMBL11339222 0.94 SIRT2 (0.53) MAPTKMT2AGRIN2DGRIN3BGRIN1
SCHEMBL11325013 0.90 KMT2A (0.50) MAPTKMT2AGRIN2DGRIN3BGRIN1
SCHEMBL11325016 0.90 KMT2A (0.50) MAPTKMT2AGRIN2DGRIN3BGRIN1
SCHEMBL7827928 0.84 MEN1 (0.64) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7827926 0.84 MEN1 (0.64) KMT2AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL20871105 0.81 MAPT (0.62) MAPTKMT2APOLBL3MBTL1ALDH1A1
SCHEMBL27818030 0.81 MAPT (0.62) MAPTKMT2APOLBL3MBTL1ALDH1A1
SCHEMBL14337245 0.80 POLB (0.52) MAPTKMT2APOLBL3MBTL1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843866-A YAP1 inhibitors targeting YAP1 interaction with OCT4 H·李·莫菲特癌症中心研究有限公司 2019-06-04 CN disclosed
US-9796676-B2 Honeybee repellents and uses thereof INSCENT, INC. (US) 2017-10-24 US disclosed
US-20160251312-A1 Honeybee Repellents and Uses Thereof INSCENT, INC. (US) 2016-09-01 US disclosed
US-9357781-B2 Honeybee repellents and uses thereof INSCENT, INC. (US) 2016-06-07 US disclosed
US-20140329674-A1 Honeybee Repellents and Uses Thereof INSCENT, INC. (US) 2014-11-06 US disclosed
US-5374701-A Crosslinkable polymers of high strength free of structural defects HAY ALLAN S (CA) 1994-12-20 US disclosed
US-5233046-A DIARYLACETYLENES, ENAMINES AND ACETYLENIC POLYMERS AND THEIR PRODUCTION HAY ALLAN S (CA) 1993-08-03 US disclosed
WO-1993009079-A1 DIARYLACETYLENES, ENAMINES AND ACETYLENIC POLYMERS AND THEIR PRODUCTION HAY ALAN S (CA) 1993-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160251312-A1 Honeybee Repellents and Uses Thereof ACHE, AHNAK, L3MBTL3 MAPT 1877/4885KMT2A 794/4885GRIN2D 259/4885
US-20140329674-A1 Honeybee Repellents and Uses Thereof ACHE, AHNAK, L3MBTL3 MAPT 1877/4885KMT2A 794/4885GRIN2D 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.